Capital Health Regional Medical Center is a member of Capital Health System. Located in Trenton, New Jersey, Capital Health Regional Medical Center, is a regional academic medical center and state designated trauma center that cares for both complex and routine cases.

There are 265 beds in Capital Health System Regional Cancer Center.

During the past decade, Capital Health System Regional Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 6 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Capital Health System Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Capital Health System Regional Cancer Center" are "Breast Cancer" (3 trials), "Prostate Cancer" (2 trials), "Anal Cancer" (1 trials), "Colorectal Cancer" (1 trials) and "Head and Neck Cancer" (1 trials). Many other conditions were trialed in "Capital Health System Regional Cancer Center" in a lesser frequency.

Most popular intervention types in "Capital Health System Regional Cancer Center" are "Drug" (7 trials), "Radiation" (6 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "anastrozole" (2 trials), "cisplatin" (2 trials), "radiation therapy" (2 trials), "5-fluorouracil" (1 trials) and "AA" (1 trials). Other intervention names were less common.

The vast majority of trials in "Capital Health System Regional Cancer Center" are 4 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Capital Health System Regional Cancer Center". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Capital Health System Regional Cancer Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Capital Health System Regional Cancer Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".